Lidocaine 1% + Epinephrine 1:100 — Class II drug recall D-0130-2019
Terminated recall by RXQ Compounding LLC, reported 2018-10-31, distributed nationwide. Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
| Recall number | D-0130-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RXQ Compounding LLC, Athens, OH, United States |
| Recall initiated | 2018-09-25 |
| Classified | 2018-11-01 |
| Reported by FDA | 2018-10-31 |
| Terminated | 2022-10-18 |
| Distributed | Nationwide (US) |
| Quantity | 395 vials |
| Reason classes | potency |
| Expiration dates | 2018-10-17 |
Product
Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701. NDC 7073197450
Reason for recall
Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0130-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.